Source: Health Canada shortage reports · Updated Jul 9, 2026
Tetrabenazine has no current shortage reported in Canada. It has been in shortage before; the history is below.
A medicine used to treat involuntary movements (chorea) in Huntington's disease.
Products affected
0 / 4
Reports on file
15
Shortage history
Shortage history (red bands = periods in shortage).
Reports by product
The DIN is printed on your prescription label.
Resolved
APO-TETRABENAZINE
25MG · TABLET · APOTEX INC
DIN 02407590 · ended Mar 20, 2025 · Disruption of the manufacture of the drug.
Resolved
APO-TETRABENAZINE
25MG · TABLET · APOTEX INC
DIN 02407590 · ended Sep 19, 2024 · Disruption of the manufacture of the drug.
Resolved
APO-TETRABENAZINE
25MG · TABLET · APOTEX INC
DIN 02407590 · ended Feb 1, 2024 · Disruption of the manufacture of the drug.
Resolved
APO-TETRABENAZINE
25MG · TABLET · APOTEX INC
DIN 02407590 · ended Sep 30, 2023 · Disruption of the manufacture of the drug.
Resolved
APO-TETRABENAZINE
25MG · TABLET · APOTEX INC
DIN 02407590 · ended Jun 22, 2023 · Disruption of the manufacture of the drug.
Resolved
APO-TETRABENAZINE
25MG · TABLET · APOTEX INC
DIN 02407590 · ended Mar 3, 2023 · Disruption of the manufacture of the drug.
Resolved
NITOMAN
25MG · TABLET · BAUSCH HEALTH, CANADA INC.
DIN 02199270 · ended May 17, 2022 · awaiting documents from supplier
Resolved
APO-TETRABENAZINE
25MG · TABLET · APOTEX INC
DIN 02407590 · ended Sep 3, 2021 · Disruption of the manufacture of the drug.
Resolved
APO-TETRABENAZINE
25MG · TABLET · APOTEX INC
DIN 02407590 · ended Apr 30, 2021 · Disruption of the manufacture of the drug.
Resolved
APO-TETRABENAZINE
25MG · TABLET · APOTEX INC
DIN 02407590 · ended Oct 9, 2020 · Disruption of the manufacture of the drug.
Resolved
PMS-TETRABENAZINE
25MG · TABLET · PHARMASCIENCE INC
DIN 02402424 · ended Oct 31, 2019 · Disruption of the manufacture of the drug.
Resolved
TETRABENAZINE TABLETS
25MG · TABLET · STERIMAX INC
DIN 02410338 · ended Jun 22, 2018 · Product is available
Showing 12 of 15 reports. All reports are on file with Health Canada.
What's happening
There are no active shortage reports for Tetrabenazine. Health Canada has 15 historical reports on file for this drug, so supply has been disrupted before; the change log below shows the history.
Tetrabenazine is classified under “OTHER NERVOUS SYSTEM DRUGS” (ATC N07XX).
Recent changes
No changes recorded yet.
Common questions
What is Tetrabenazine used for?
A medicine used to treat involuntary movements (chorea) in Huntington's disease.
When will Tetrabenazine be back in stock in Canada?
Tetrabenazine has no active shortage; supply is normal per Health Canada reports.
Why is Tetrabenazine in shortage?
It isn't currently. Past reports and their reasons are listed above.
What can my pharmacist do about it?
Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.
Email alerts
Get an email when this drug's status changes. Double opt-in, one-click unsubscribe.
Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.